(Q37629253)

21 August 2017

1 reference

title

Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity (English)

1 reference

21 August 2017

0 references

1 reference

1 reference

Taizo Kita

1

1 reference

21 August 2017

Ikuko Miyazaki

2

1 reference

21 August 2017

Masato Asanuma

3

1 reference

21 August 2017

Mika Takeshima

4

1 reference

21 August 2017

George C Wagner

5

1 reference

21 August 2017

1 January 2009

1 reference

International Review of Neurobiology

21 August 2017

1 reference

21 August 2017

88

1 reference

21 August 2017

43-64

1 reference

Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

alpha-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Free radicals and the pathobiology of brain dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

alpha-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Methamphetamine-induced neuronal damage: a possible role for free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Ribosomal S6 kinase signaling and the control of translation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Catecholamines oxidation by xanthine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Amphetamine exposure is elevated in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behaviour and long term dopamine depletion in BALB/c and C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Overexpression of Cu-Zn superoxide dismutase protects neuroblastoma cells against dopamine cytotoxicity accompanied by increase in their glutathione level

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Enzymatic oxidation of dopamine: the role of prostaglandin H synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Mammalian tyrosinase. A comparison of tyrosine hydroxylation and melanin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: immunohistochemical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Conjugation of dopa and 5-S-cysteinyldopa with cysteine mediated by superoxide radical.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Methamphetamine-induced changes in activity and water intake during light and dark cycles in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Cellular and molecular mechanisms of drug dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Tyrosinase-catalyzed oxidation of dopa and related catechol(amine)s: a kinetic electron spin resonance investigation using spin-stabilization and spin label oximetry

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine covalently modifies and functionally inactivates parkin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

The role of vesicular transport proteins in synaptic transmission and neural degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11C]WIN 35,428 - positron emission tomography studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Implications of chronic methamphetamine use: a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Oxidative stress in methamphetamine-induced self-injurious behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Effects of butylated hydroxyanisole and dicoumarol on the toxicity of menadione to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Anatomical substrates for the discriminative stimulus effects of methamphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha, and an inducer of these factors in drug dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Amphetamine neurotoxicity on dopamine nerve terminals in the caudate nucleus of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Lipoxygenase-Catalyzed Oxidation of Catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Cocaine, in contrast to D-amphetamine, does not cause axonal terminal degeneration in neostriatum and agranular frontal cortex of Long-Evans rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Treatment of mice with methamphetamine produces cell loss in the substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Intraneuronal dopamine-quinone synthesis: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Regulation of the tyrosinase promoter in transgenic mice: expression of a tyrosinase-lacZ fusion gene in embryonic and adult brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Potential oxidative pathways of brain catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Neurochemical similarities between d,l-cathinone and d-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Tolerance following the repeated administration of high doses of phencyclidine: no relation to central catecholamine depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Risperidone reduction of amphetamine-induced self-injurious behavior in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988003-3

1 reference

7 January 2021

10.1016/S0074-7742(09)88003-3

Identifiers

DOI

1 reference

21 August 2017

1 reference